NCT01833494View on ClinicalTrials.gov

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

March 18, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 4, 2014

Conditions
Hemodialysis Patients With Hyperphosphatemia
Interventions
DRUG

PA21

Trial Locations (1)

Unknown

JAPAN, Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY